The U.S. Food and Drug Administration proposed on Monday a new framework to speed approvals of personalized treatments for ...
With 300 million people living with rare diseases, experts say new gene and cell therapies are giving families in Wisconsin hope for lasting treatment options.
After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate.
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will ...